JAMA Oncology is an international peer-reviewed journal and the definitive journal for scientists, clinicians, and trainees in the field of oncology. JAMA Oncology is a member of the JAMA Network family of journals, which includes JAMA, 11 JAMA Network specialty journals, and JAMA Network Open.
Journal Frequency and Access. JAMA Oncology is published online weekly, every Thursday, and in 12 print/online issues a year. The journal receives over 1.8 million online visits annually and more than 2.4 million article views and downloads. Without any author fees, all research articles are made free access online 12 months after publication on the website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program.
Editorial Information. The journal’s acceptance rate is 11%. The median time to first decision is 2 days, and 40 days with review. The journal's Impact Factor is 22.4, one of the highest ranking among oncology journals. All articles are published online first. Additional information on the types of articles published and editorial policies is available in the journal's Instructions for Authors.
Editorial Team. The founding Editor in Chief of JAMA Oncology is Mary L. (Nora) Disis, MD. Dr Disis is director of the UW Institute of Translational Health Science and the Center for Translational Medicine in Women's Health. She is also associate dean of the UW School of Medicine, dean of Research and Graduate Education, associate dean of Translational Science, Helen B. Slonaker Endowed Professor for Cancer Research, professor of Medicine and Oncology, and adjunct professor of Obstetrics & Gynecology and Pathology. For a complete listing of the journal's Editors and Editorial Board, see Editors and Publishers.
Mission Statement. JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
ISSN 2374-2437 (Print)
ISSN 2374-2445 (Online)
Back to top
JAMA Oncology is committed to publishing influential original research, opinions, and reviews that advance the science of oncology and improve the clinical care of patients with cancer.
For more information, see JAMA Oncology Instructions for Authors. Submit your manuscript at https://manuscripts.jamaonc.com.
Updated July 2019
JAMA Network attends a variety of medical conferences across specialties throughout the world.
Create a personal account or sign in to: